alternatives to glp-1 agonists How Receptor Evolved from Diabetes Weight Loss Treatments | https://lnkd.in/gH3rfnVe Thursday, March 14, 2024 8am PST // 11am EST // 4pm GMT Peptidic GLP-1R agonists have received… Comparing Ozempic, Wegovy and Other

Lipo-C injections can also help facilitate rapid fat and weight loss by converting fat into an energy source

This acetate version stays stable and resists going off, helping to extend a product's shelf life

Rheum Dis Clin North Am

Trials still pending Two core obesity trials are still running: TRIUMPH-2 (obesity + type 2 diabetes) results expected later 2026 TRIUMPH-3 (obesity + established cardiovascular disease) results expected later 2026 A separate cardiovascular outcomes trial, TRIUMPH-Outcomes (~10,000 patients), is not required for the initial obesity NDA and wont report until 20282029

Description Ipamorelin is a synthetic pentapeptide